Barbara Gayle Duncan, Director at Jounce Therapeutics, Inc. (JNCE), sold 4,000 shares at $25.00 ($100K) on 2018-01-26, disclosed to the SEC on 2018-01-29.
Open-market sale of $100k JNCE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GNMX | BUY | 2017-10-18 | $150K | — | Filing → |
| ICPT | SELL | 2016-10-05 | $24K | — | Filing → |
| ICPT | SELL | 2016-07-07 | $21K | — | Filing → |